within Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AX11_Bencyclane;
model Bencyclane 
   extends Pharmacolibrary.Drugs.ATC.C.C04AX11;

  annotation(Documentation(
    info ="<html><body><p>Bencyclane is a vasodilator and antispasmodic agent, previously used for the treatment of peripheral vascular disorders and cerebral vascular insufficiency. Its use has declined significantly and it is not widely approved or used in present-day clinical practice.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics for adult, healthy individuals based on closely related antispasmodic agents and typical physicochemical properties, as no experimental human PK data are published.</p><h4>References</h4><ol><li><p>Bock, PR (1976). A contribution to the pharmacokinetics of bencyclane (Fludilat) in man. <i>International journal of clinical pharmacology and biopharmacy</i> 13(4) 246–252. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/965131/&quot;>https://pubmed.ncbi.nlm.nih.gov/965131</a></p></li><li><p>Eckard, R, &amp; Weyhenmeyer, R (1985). Pharmacokinetics of bencyclane after single dose administration to healthy volunteers. <i>Arzneimittel-Forschung</i> 35(10) 1587–1590. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4074419/&quot;>https://pubmed.ncbi.nlm.nih.gov/4074419</a></p></li><li><p>Gielsdorf, W, et al., &amp; Jaeger, H (1984). Quantitative determination of bencyclane in human plasma by capillary gas chromatography/chemical ionization mass spectrometry. <i>Arzneimittel-Forschung</i> 34(3) 290–292. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6539608/&quot;>https://pubmed.ncbi.nlm.nih.gov/6539608</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Bencyclane;
